Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

563 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial.
Phillips R, Shi WY, Deek M, Radwan N, Lim SJ, Antonarakis ES, Rowe SP, Ross AE, Gorin MA, Deville C, Greco SC, Wang H, Denmeade SR, Paller CJ, Dipasquale S, DeWeese TL, Song DY, Wang H, Carducci MA, Pienta KJ, Pomper MG, Dicker AP, Eisenberger MA, Alizadeh AA, Diehn M, Tran PT. Phillips R, et al. Among authors: pomper mg. JAMA Oncol. 2020 May 1;6(5):650-659. doi: 10.1001/jamaoncol.2020.0147. JAMA Oncol. 2020. PMID: 32215577 Free PMC article. Clinical Trial.
Targeted molecular imaging in oncology: focus on radiation therapy.
Nimmagadda S, Ford EC, Wong JW, Pomper MG. Nimmagadda S, et al. Among authors: pomper mg. Semin Radiat Oncol. 2008 Apr;18(2):136-48. doi: 10.1016/j.semradonc.2007.10.009. Semin Radiat Oncol. 2008. PMID: 18314068 Free PMC article. Review.
Challenges in clinical prostate cancer: role of imaging.
Kelloff GJ, Choyke P, Coffey DS; Prostate Cancer Imaging Working Group. Kelloff GJ, et al. AJR Am J Roentgenol. 2009 Jun;192(6):1455-70. doi: 10.2214/AJR.09.2579. AJR Am J Roentgenol. 2009. PMID: 19457806 Free PMC article.
PSMA-targeted theranostic nanoplex for prostate cancer therapy.
Chen Z, Penet MF, Nimmagadda S, Li C, Banerjee SR, Winnard PT Jr, Artemov D, Glunde K, Pomper MG, Bhujwalla ZM. Chen Z, et al. Among authors: pomper mg. ACS Nano. 2012 Sep 25;6(9):7752-7762. doi: 10.1021/nn301725w. Epub 2012 Aug 9. ACS Nano. 2012. PMID: 22866897 Free PMC article.
Biodistribution, tumor detection, and radiation dosimetry of 18F-DCFBC, a low-molecular-weight inhibitor of prostate-specific membrane antigen, in patients with metastatic prostate cancer.
Cho SY, Gage KL, Mease RC, Senthamizhchelvan S, Holt DP, Jeffrey-Kwanisai A, Endres CJ, Dannals RF, Sgouros G, Lodge M, Eisenberger MA, Rodriguez R, Carducci MA, Rojas C, Slusher BS, Kozikowski AP, Pomper MG. Cho SY, et al. Among authors: pomper mg. J Nucl Med. 2012 Dec;53(12):1883-91. doi: 10.2967/jnumed.112.104661. J Nucl Med. 2012. PMID: 23203246 Free PMC article. Clinical Trial.
Initial Evaluation of [(18)F]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer.
Szabo Z, Mena E, Rowe SP, Plyku D, Nidal R, Eisenberger MA, Antonarakis ES, Fan H, Dannals RF, Chen Y, Mease RC, Vranesic M, Bhatnagar A, Sgouros G, Cho SY, Pomper MG. Szabo Z, et al. Among authors: pomper mg. Mol Imaging Biol. 2015 Aug;17(4):565-74. doi: 10.1007/s11307-015-0850-8. Mol Imaging Biol. 2015. PMID: 25896814 Free PMC article.
563 results